Walking Fish Therapeutics, Inc. – Trademark Portfolio
Entity Type: 03
Walking Fish Therapeutics, Inc. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include WALKING FISH THERAPEUTICS. The owner is based in South San Francisco, CA.
450 E. Jamie Court, Suite 300
South San Francisco, CA 94080
Showing of trademarks Trademarks
Trademark Classifications
Walking Fish Therapeutics, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Walking Fish Therapeutics, Inc. have?
Walking Fish Therapeutics, Inc. has 6 U.S. trademarks filed with the USPTO. Of these, 2 registered, 4 abandoned.
What trademark classes does Walking Fish Therapeutics, Inc. file in?
Walking Fish Therapeutics, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Walking Fish Therapeutics, Inc.'s most well-known trademarks?
Walking Fish Therapeutics, Inc.'s registered trademark portfolio includes well-known marks such as WALKING FISH THERAPEUTICS. These are among 2 currently registered trademarks in the portfolio.
What is Walking Fish Therapeutics, Inc.'s trademark registration success rate?
Walking Fish Therapeutics, Inc. has a 33% trademark registration rate, with 2 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.